共 50 条
- [21] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
- [22] Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (06): : 530 - 535
- [23] Pregnancy and cesarean delivery in a patient with dystrophic epidermolysis bullosa EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 110 (02): : 235 - 236
- [24] Combined anaesthesia in a young patient with dystrophic epidermolysis bullosa PAEDIATRIC ANAESTHESIA, 2003, 13 (03): : 274 - 274
- [28] IgA nephropathy in a patient with dominant dystrophic epidermolysis bullosa TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 214 (04): : 297 - 301